The Centers for Medicare & Medicaid Services has released a preliminary list of 101 generic drugs priced at $2 for a month’s ...

AstraZeneca has announced promising results from the BATURA Phase IIIb trial, showcasing the effectiveness of AIRSUPRA ...

Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants1 CHARLOTTE, N.C., October, 2024 – Honeywell (NASDAQ: HON) today announced a long ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

An initial list of 101 generic drugs available to those enrolled in the government's Medicare program for no more than $2 for ...

Topline results were announced from a trial evaluating albuterol/budesonide inhaler in patients with intermittent or mild persistent asthma.

Learn about the Biden administration's plan to offer Medicare pilot program for affordable generic drugs, including common ...

The U.S. government plans to release a list of 101 generic drugs, available to Medicare recipients for no more than $2 each. These drugs, including penicillin and albuterol, won't require prior ...

"AstraZeneca’s Phase III trial of treatment for asthma meets its primary endpoint" was originally created and published by ...

AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint: Cambridge, UK Tuesday, October 8, 2024, 09:00 H ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...